US PAYER NEEDS FOR VALUE DEMONSTRATION FOR IGG THERAPIES
Publication
, Conference
Brogan, AP; Guptill, JT; Runken, MC; Hogue, S
Published in: Value in Health
May 2016
Duke Scholars
Published In
Value in Health
DOI
ISSN
1098-3015
Publication Date
May 2016
Volume
19
Issue
3
Start / End Page
A254 / A254
Publisher
Elsevier BV
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Brogan, A. P., Guptill, J. T., Runken, M. C., & Hogue, S. (2016). US PAYER NEEDS FOR VALUE DEMONSTRATION FOR IGG THERAPIES. In Value in Health (Vol. 19, pp. A254–A254). Elsevier BV. https://doi.org/10.1016/j.jval.2016.03.1015
Brogan, A. P., J. T. Guptill, M. C. Runken, and S. Hogue. “US PAYER NEEDS FOR VALUE DEMONSTRATION FOR IGG THERAPIES.” In Value in Health, 19:A254–A254. Elsevier BV, 2016. https://doi.org/10.1016/j.jval.2016.03.1015.
Brogan AP, Guptill JT, Runken MC, Hogue S. US PAYER NEEDS FOR VALUE DEMONSTRATION FOR IGG THERAPIES. In: Value in Health. Elsevier BV; 2016. p. A254–A254.
Brogan, A. P., et al. “US PAYER NEEDS FOR VALUE DEMONSTRATION FOR IGG THERAPIES.” Value in Health, vol. 19, no. 3, Elsevier BV, 2016, pp. A254–A254. Crossref, doi:10.1016/j.jval.2016.03.1015.
Brogan AP, Guptill JT, Runken MC, Hogue S. US PAYER NEEDS FOR VALUE DEMONSTRATION FOR IGG THERAPIES. Value in Health. Elsevier BV; 2016. p. A254–A254.
Published In
Value in Health
DOI
ISSN
1098-3015
Publication Date
May 2016
Volume
19
Issue
3
Start / End Page
A254 / A254
Publisher
Elsevier BV
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services